BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Handel A, Margolis E, Levin BR. Exploring the role of the immune response in preventing antibiotic resistance. J Theor Biol 2009;256:655-62. [PMID: 19056402 DOI: 10.1016/j.jtbi.2008.10.025] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Tetteh JNA, Matthäus F, Hernandez-Vargas EA. A survey of within-host and between-hosts modelling for antibiotic resistance. Biosystems 2020;196:104182. [PMID: 32525023 DOI: 10.1016/j.biosystems.2020.104182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ternent L, Dyson RJ, Krachler AM, Jabbari S. Bacterial fitness shapes the population dynamics of antibiotic-resistant and -susceptible bacteria in a model of combined antibiotic and anti-virulence treatment. J Theor Biol 2015;372:1-11. [PMID: 25701634 DOI: 10.1016/j.jtbi.2015.02.011] [Cited by in Crossref: 38] [Cited by in F6Publishing: 21] [Article Influence: 5.4] [Reference Citation Analysis]
3 Burmeister AR, Hansen E, Cunningham JJ, Rego EH, Turner PE, Weitz JS, Hochberg ME. Fighting microbial pathogens by integrating host ecosystem interactions and evolution. Bioessays 2021;43:e2000272. [PMID: 33377530 DOI: 10.1002/bies.202000272] [Reference Citation Analysis]
4 Pan AJ, Mei Q, Ye Y, Li HR, Liu B, Li JB. Validation of the mutant selection window hypothesis with fosfomycin against Escherichia coli and Pseudomonas aeruginosa: an in vitro and in vivo comparative study. J Antibiot (Tokyo) 2017;70:166-73. [PMID: 27756910 DOI: 10.1038/ja.2016.124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 Levin BR, Baquero F, Ankomah PP, McCall IC. Phagocytes, Antibiotics, and Self-Limiting Bacterial Infections. Trends Microbiol. 2017;25:878-892. [PMID: 28843668 DOI: 10.1016/j.tim.2017.07.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 5.6] [Reference Citation Analysis]
6 Djidjou-Demasse R, Alizon S, Sofonea MT. Within-host bacterial growth dynamics with both mutation and horizontal gene transfer. J Math Biol 2021;82:16. [PMID: 33544239 DOI: 10.1007/s00285-021-01571-9] [Reference Citation Analysis]
7 Gjini E, Paupério FFS, Ganusov VV. Treatment timing shifts the benefits of short and long antibiotic treatment over infection. Evol Med Public Health 2020;2020:249-63. [PMID: 33376597 DOI: 10.1093/emph/eoaa033] [Reference Citation Analysis]
8 Anuforom O, Wallace GR, Piddock LV. The immune response and antibacterial therapy. Med Microbiol Immunol 2015;204:151-9. [PMID: 25189424 DOI: 10.1007/s00430-014-0355-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
9 Garcia E, Ly N, Diep JK, Rao GG. Moving From Point‐Based Analysis to Systems‐Based Modeling: Integration of Knowledge to Address Antimicrobial Resistance Against MDR Bacteria. Clin Pharmacol Ther. [DOI: 10.1002/cpt.2219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Alizon S, Luciani F, Regoes RR. Epidemiological and clinical consequences of within-host evolution. Trends Microbiol 2011;19:24-32. [PMID: 21055948 DOI: 10.1016/j.tim.2010.09.005] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
11 Schulz zur Wiesch P, Engelstädter J, Bonhoeffer S. Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob Agents Chemother 2010;54:2085-95. [PMID: 20176903 DOI: 10.1128/AAC.01460-09] [Cited by in Crossref: 104] [Cited by in F6Publishing: 46] [Article Influence: 8.7] [Reference Citation Analysis]
12 Hansen E, Woods RJ, Read AF. How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient. PLoS Biol 2017;15:e2001110. [PMID: 28182734 DOI: 10.1371/journal.pbio.2001110] [Cited by in Crossref: 76] [Cited by in F6Publishing: 52] [Article Influence: 15.2] [Reference Citation Analysis]
13 Mei Q, Ye Y, Zhu YL, Cheng J, Yang HF, Liu YY, Li HR, Li JB. Use of Monte Carlo simulation to evaluate the development of vancomycin resistance in meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents 2015;45:652-6. [PMID: 25813394 DOI: 10.1016/j.ijantimicag.2015.01.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
14 Roberts PA, Huebinger RM, Keen E, Krachler AM, Jabbari S. Mathematical model predicts anti-adhesion-antibiotic-debridement combination therapies can clear an antibiotic resistant infection. PLoS Comput Biol 2019;15:e1007211. [PMID: 31335907 DOI: 10.1371/journal.pcbi.1007211] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
15 Huijben S, Bell AS, Sim DG, Tomasello D, Mideo N, Day T, Read AF. Aggressive chemotherapy and the selection of drug resistant pathogens. PLoS Pathog 2013;9:e1003578. [PMID: 24068922 DOI: 10.1371/journal.ppat.1003578] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 6.2] [Reference Citation Analysis]
16 Shen S, Wu W, Grimes DJ, Saillant EA, Griffitt RJ. Community composition and antibiotic resistance of bacteria in bottlenose dolphins Tursiops truncatus - Potential impact of 2010 BP Oil Spill. Sci Total Environ 2020;732:139125. [PMID: 32438143 DOI: 10.1016/j.scitotenv.2020.139125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Michelet R, Ursino M, Boulet S, Franck S, Casilag F, Baldry M, Rolff J, van Dyk M, Wicha SG, Sirard JC, Comets E, Zohar S, Kloft C. The Use of Translational Modelling and Simulation to Develop Immunomodulatory Therapy as an Adjunct to Antibiotic Treatment in the Context of Pneumonia. Pharmaceutics 2021;13:601. [PMID: 33922017 DOI: 10.3390/pharmaceutics13050601] [Reference Citation Analysis]
18 Baquero F, Coque TM, Cantón R. Counteracting antibiotic resistance: breaking barriers among antibacterial strategies. Expert Opinion on Therapeutic Targets 2014;18:851-61. [DOI: 10.1517/14728222.2014.925881] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
19 Castro RAD, Ross A, Kamwela L, Reinhard M, Loiseau C, Feldmann J, Borrell S, Trauner A, Gagneux S. The Genetic Background Modulates the Evolution of Fluoroquinolone-Resistance in Mycobacterium tuberculosis. Mol Biol Evol 2020;37:195-207. [PMID: 31532481 DOI: 10.1093/molbev/msz214] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
20 Shaviya N, Budambula V, Webale MK, Were T. Circulating Interferon-Gamma Levels Are Associated with Low Body Weight in Newly Diagnosed Kenyan Non-Substance Using Tuberculosis Individuals. Interdiscip Perspect Infect Dis 2016;2016:9415364. [PMID: 26880909 DOI: 10.1155/2016/9415364] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
21 Geli P, Laxminarayan R, Dunne M, Smith DL. "One-size-fits-all"? Optimizing treatment duration for bacterial infections. PLoS One 2012;7:e29838. [PMID: 22253798 DOI: 10.1371/journal.pone.0029838] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 4.7] [Reference Citation Analysis]
22 Mariam SH, Werngren J, Aronsson J, Hoffner S, Andersson DI. Dynamics of antibiotic resistant Mycobacterium tuberculosis during long-term infection and antibiotic treatment. PLoS One 2011;6:e21147. [PMID: 21698208 DOI: 10.1371/journal.pone.0021147] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
23 Acosta MM, Bram JT, Sim D, Read AF. Effect of drug dose and timing of treatment on the emergence of drug resistance in vivo in a malaria model. Evol Med Public Health 2020;2020:196-210. [PMID: 33209305 DOI: 10.1093/emph/eoaa016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Fathalla AM, Chow SH, Naderer T, Zhou QT, Velkov T, Azad MAK, Li J. Polymyxin-Induced Cell Death of Human Macrophage-Like THP-1 and Neutrophil-Like HL-60 Cells Associated with the Activation of Apoptotic Pathways. Antimicrob Agents Chemother 2020;64:e00013-20. [PMID: 32660985 DOI: 10.1128/AAC.00013-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Yu G, Baeder DY, Regoes RR, Rolff J. Combination Effects of Antimicrobial Peptides. Antimicrob Agents Chemother 2016;60:1717-24. [PMID: 26729502 DOI: 10.1128/AAC.02434-15] [Cited by in Crossref: 97] [Cited by in F6Publishing: 56] [Article Influence: 16.2] [Reference Citation Analysis]
26 Martinez MN, Papich MG, Drusano GL. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrob Agents Chemother 2012;56:2795-805. [PMID: 22371890 DOI: 10.1128/AAC.05360-11] [Cited by in Crossref: 121] [Cited by in F6Publishing: 55] [Article Influence: 12.1] [Reference Citation Analysis]
27 Margolis E, Rosch JW. Fitness Landscape of the Immune Compromised Favors the Emergence of Antibiotic Resistance. ACS Infect Dis 2018;4:1275-7. [PMID: 30070470 DOI: 10.1021/acsinfecdis.8b00158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 zur Wiesch PA, Kouyos R, Engelstädter J, Regoes RR, Bonhoeffer S. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect Dis 2011;11:236-47. [PMID: 21371657 DOI: 10.1016/S1473-3099(10)70264-4] [Cited by in Crossref: 153] [Cited by in F6Publishing: 89] [Article Influence: 13.9] [Reference Citation Analysis]
29 Li Y, Handel A. Modeling inoculum dose dependent patterns of acute virus infections. J Theor Biol 2014;347:63-73. [PMID: 24440713 DOI: 10.1016/j.jtbi.2014.01.008] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
30 Juška A. Minimal models of growth and decline of microbial populations. J Theor Biol 2011;269:195-200. [PMID: 21036180 DOI: 10.1016/j.jtbi.2010.10.030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
31 Jiang L, Xie N, Chen M, Liu Y, Wang S, Mao J, Li J, Huang X. Synergistic Combination of Linezolid and Fosfomycin Closing Each Other's Mutant Selection Window to Prevent Enterococcal Resistance. Front Microbiol 2020;11:605962. [PMID: 33633692 DOI: 10.3389/fmicb.2020.605962] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Diep JK, Russo TA, Rao GG. Mechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii Pneumonia. CPT Pharmacometrics Syst Pharmacol 2018;7:507-16. [PMID: 29761668 DOI: 10.1002/psp4.12312] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
33 Gedik H. Does antimicrobial use increase the rate of antimicrobial resistance? A one year experience. Indian Journal of Medical Microbiology 2012;30:198-202. [DOI: 10.4103/0255-0857.96692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Mei Q, Ye Y, Zhu YL, Cheng J, Chang X, Liu YY, Li HR, Li JB. Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin. Eur J Clin Microbiol Infect Dis 2015;34:737-44. [PMID: 25424036 DOI: 10.1007/s10096-014-2285-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
35 Boulouis C, Sia WR, Gulam MY, Teo JQM, Png YT, Phan TK, Mak JYW, Fairlie DP, Poon IKH, Koh TH, Bergman P, Lim CM, Wang LF, Kwa ALH, Sandberg JK, Leeansyah E. Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli. PLoS Biol 2020;18:e3000644. [PMID: 32511236 DOI: 10.1371/journal.pbio.3000644] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
36 Hood G, Hand KS, Cramp E, Howard P, Hopkins S, Ashiru-Oredope D. Measuring Appropriate Antibiotic Prescribing in Acute Hospitals: Development of a National Audit Tool Through a Delphi Consensus. Antibiotics (Basel) 2019;8:E49. [PMID: 31035663 DOI: 10.3390/antibiotics8020049] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
37 Alexander HK, Martin G, Martin OY, Bonhoeffer S. Evolutionary rescue: linking theory for conservation and medicine. Evol Appl 2014;7:1161-79. [PMID: 25558278 DOI: 10.1111/eva.12221] [Cited by in Crossref: 71] [Cited by in F6Publishing: 35] [Article Influence: 8.9] [Reference Citation Analysis]
38 Handel A, Longini IM Jr, Antia R. Towards a quantitative understanding of the within-host dynamics of influenza A infections. J R Soc Interface 2010;7:35-47. [PMID: 19474085 DOI: 10.1098/rsif.2009.0067] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 7.6] [Reference Citation Analysis]
39 Kwon Y, Park C, Lee J, Park DH, Jeong S, Yun CH, Park OJ, Han SH. Regulation of Bone Cell Differentiation and Activation by Microbe-Associated Molecular Patterns. Int J Mol Sci 2021;22:5805. [PMID: 34071605 DOI: 10.3390/ijms22115805] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Ankomah P, Levin BR. Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections. Proc Natl Acad Sci USA. 2014;111:8331-8338. [PMID: 24843148 DOI: 10.1073/pnas.1400352111] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 8.6] [Reference Citation Analysis]
41 Gómez MA, Navas A, Prieto MD, Giraldo-Parra L, Cossio A, Alexander N, Gore Saravia N. Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia). Clin Infect Dis 2021;72:e484-92. [PMID: 32818964 DOI: 10.1093/cid/ciaa1206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
42 Brites D, Gagneux S. Old and new selective pressures on Mycobacterium tuberculosis. Infect Genet Evol 2012;12:678-85. [PMID: 21867778 DOI: 10.1016/j.meegid.2011.08.010] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
43 Naik P, Singh S, Vishwakarma S, Kaur I, Dave VP, Kumar A, Joseph J. Multidrug-Resistant Pseudomonas aeruginosa Evokes Differential Inflammatory Responses in Human Microglial and Retinal Pigment Epithelial Cells. Microorganisms 2020;8:E735. [PMID: 32423093 DOI: 10.3390/microorganisms8050735] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
44 Gjini E, Brito PH. Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment. PLoS Comput Biol 2016;12:e1004857. [PMID: 27078624 DOI: 10.1371/journal.pcbi.1004857] [Cited by in Crossref: 53] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]